Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Debt to Equity (2018 - 2025)

Dna X filings provide 7 years of Debt to Equity readings, the most recent being -$0.02 for Q4 2025.

  • On a quarterly basis, Debt to Equity changed N/A to -$0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.02, a N/A change, with the full-year FY2025 number at -$0.02, changed N/A from a year prior.
  • Debt to Equity hit -$0.02 in Q4 2025 for Dna X, up from -$0.36 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.02 in Q2 2021 to a low of -$0.52 in Q1 2025.
  • Median Debt to Equity over the past 4 years was $0.01 (2022), compared with a mean of -$0.05.
  • The widest YoY moves for Debt to Equity: up 89.5% in 2021, down 97.44% in 2021.
  • Dna X's Debt to Equity stood at $0.01 in 2021, then crashed by 36.16% to $0.01 in 2022, then tumbled by 78.17% to $0.0 in 2023, then tumbled by 1442.62% to -$0.02 in 2025.
  • The last three reported values for Debt to Equity were -$0.02 (Q4 2025), -$0.36 (Q3 2025), and -$0.52 (Q1 2025) per Business Quant data.